Clinical Trial Update: TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TTFields with radiosurgery for recurrent glioblastoma, with auxiliary imaging using 18F-Fluoro-Ethyl-Thyrosine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioblastoma Multiforme

Drugs mentioned

• TTFields (Tumor Treating Fields)

Snippet

Sponsor: Prof. Franciszek Lukaszczyk Memorial Oncology Center | Conditions: Glioblastoma Multiforme, Recurrent Glioblastoma | Phase 2 | Status: UNKNOWN